MedPath

Altering the timing of breakfast and exercise to modify post-meal glucose concentrations: The Breakfast and Exercise Timing (BET) Study

Not Applicable
Completed
Conditions
Type 2 diabetes
Metabolic and Endocrine - Diabetes
Registration Number
ACTRN12622001177741
Lead Sponsor
Dr Evelyn Parr
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
14
Inclusion Criteria

Community dwelling persons 30 – 65 years old.
-Diagnosed (by GP/Endocrinologist) with T2D, with an HbA1c between 6.5%-<10%, measured within 3 months of enrolment.
-Not currently taking sulphonylureas or insulin or more than 2 Oral Hypoglycaemic Agents.
-Able to travel to the Fitzroy campus independently

Exclusion Criteria

-Currently meeting physical activity guidelines (>150 min/week).
-Currently following a ketogenic (i.e., <50 g CHO/day) diet, or following a restricted time diet (i.e., TRE, alternate day fasting or other forms of intermittent fasting).
-Unwilling to consume breakfast for the study period.
-Unable to adequately complete dietary monitoring, habitual dietary monitoring period or eating breakfast at the prescribed times.
-Unable to adequately complete 20 minutes of brisk walking after breakfast.
-Shift workers (i.e., more than 1 shift per month between 10:00 pm and 5:00 am)
-Smokers, including e-cigarettes, tobacco or marijuana, or within 3 months of quitting
-History of psychotic disorder, or current diagnosis of other major psychiatric illness (e.g. mood disorder, eating disorder, substance use disorder); and diagnosed gastrointestinal conditions.
-Women who are pregnant, breastfeeding (within 24 wk).
-Currently taking diuretic medication (contraindication to fasting) or medications known to interact with glucose metabolism;
-Changed medications within 3 months.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath